- Home
- SCWO vs FENC Comparison
SCWO vs FENC Comparison
Compare SCWO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCWO | FENC |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 263.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | SCWO | FENC |
|---|---|---|
| Price | $2.83 | $7.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 40.0K | ★ 113.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $47,538,000.00 |
| Revenue This Year | $5,945.19 | N/A |
| Revenue Next Year | $106.82 | $70.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.69 |
| 52 Week Low | $0.16 | $4.68 |
| 52 Week High | $3.55 | $9.92 |
Technical Indicators
Market Signals| Indicator | SCWO | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 45.28 |
| Support Level | $2.35 | $7.44 |
| Resistance Level | $3.10 | $8.27 |
| Average True Range (ATR) | 0.21 | 0.46 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 79.47 | 26.59 |
Price Performance
Historical ComparisonAbout SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.